DANZITEN CONNECT
Live / Applied — Statement of use — registration review complete (as of 17 Aug 2026)
What this means for you
Not registered yet, but its 15 Oct 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98801554
- Mark type
- Stylized text
- Filed
- 15 Oct 2024
- Published for opposition
- 26 Aug 2025
- Attorney of record
- Douglas R. Wolf
Goods and services
- Class 035 — Advertising and business services: Providing patient support services, namely, providing drug access to patients via administration of a discount program for enabling participants to obtain discounts on the cost of drugs
- Class 036 — Insurance and financial services: Providing patient support services, namely, providing financial support to patients for obtaining medications
- Class 044 — Medical, beauty and agricultural services: Providing patient support services, namely, providing medical information relating to oncological diseases and pharmaceuticals used to treat oncological diseases
- Class 045 — Legal and security services: Providing patient support and advocate services featuring administration for medical treatments in the nature of coordinating the procurement and administration of medication
Owner
- Azurity Pharmaceuticals, Inc., Woburn, MA, US
- Azurity Pharmaceuticals, Inc., Woburn, MA, US
Prosecution history
- 08 Sept 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 08 Sept 2026 — REGISTERED-PRINCIPAL REGISTER
- 17 Aug 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 17 Aug 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 14 Aug 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 14 Aug 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 13 Aug 2026 — ASSIGNED TO LIE
- 11 Aug 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 29 Jul 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Jul 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 28 Jul 2026 — NON-FINAL ACTION E-MAILED
- 28 Jul 2026 — SU - NON-FINAL ACTION - WRITTEN
- 28 Jul 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 30 Oct 2025 — USE AMENDMENT FILED
- 28 Jul 2026 — SOU EXTENSION 1 GRANTED